EP0042, a Dual FLT3 and Aurora Kinase Inhibitor: Results from an Ongoing Phase I/IIa Dose-Finding/Dose Optimization Study in Patients with Relapsed/Refractory Acute Myeloid LeukemiaDavid Taussig,David C. de Leeuw,Mojca Jongen-Lavrencic,Jenny O'Nions,Thinzar Koko,Emma Searle,Hendrik-Tobias Arkenau,Sue Brook,Charlotte Burmester,Geoff Fisher, Katie Stoddart,Peter TanBLOOD（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
